AM-301, a barrier-forming nasal spray, versus saline spray in seasonal allergic rhinitis: A randomized clinical trial.

Sven Becker Sachin Deshmukh Ferdinandus de Looze Veronica Francardo Jessie Lee Anthony McGirr Zachary Nathan Christopher Rook Thomas Meyer

Published in: Allergy (2024)

AM-301 was more effective than saline in improving SAR nasal symptoms and related quality of life while offering similar tolerability, demonstrating the benefits of a barrier approach.

Keyphrases

allergic rhinitis
chronic rhinosinusitis
open label
clinical trial
randomized controlled trial
sleep quality
double blind
placebo controlled